Navigation Links
UNC physician authors editorial on cost-effectiveness study for colon cancer screening
Date:7/27/2010

Chapel Hill - A UNC physician authored an editorial in the July 27 online issue of the Journal of the National Cancer Institute (JNCI) commenting on results of an analysis of the cost effectiveness of colonoscopy versus computed tomographic colonography (CTC).

The cost effectiveness analysis concluded that CTC or "virtual" colonoscopy is not cost effective compared with colonoscopy if reimbursed at the same rate as colonoscopy.

Both CT colonography and colonoscopy examine the inside of the colon (the large intestine) for either cancer or large polyps (growths that could become cancer). CTC colonography does this examination indirectly, using a CT scan (a type of x-ray). Colonoscopy does this examination directly, using a camera on the end of a tube inserted into the colon.

Unfortunately, there has been no "comparative effectiveness" study to compare the benefits and harms of CTC with colonoscopy. So the researchers in the JNCI article used simulation models to compare the two tests in an unscreened population of Medicare beneficiaries ages 65 to 80 years. These models use mathematics to estimate what would happen if one used one test compared with the other.

Russell Harris, MD, MPH, professor of medicine at UNC and a member of UNC Lineberger Comprehensive Cancer Center, wrote the editorial accompanying the cost-effectiveness study.

In his editorial, Harris notes that cost-effectiveness analyses are useful, but that they often cannot include some important considerations. In this case, Harris shows how the cost-effectiveness analysis could not include some of the potential harms of both CTC and colonoscopy. For example, CTC often leads to finding abnormalities outside the colon (such as in the kidneys or adrenal glands) that require further testing and even surgery, yet finding these abnormalities usually does not help people live longer.

Colonoscopy often leads to removing small polyps that do not need to be removed, yet their removal may lead to complications such as excessive bleeding.

In the end, Harris suggests that neither CTC nor colonoscopy are ideal screening tests. He concludes: "Wouldn't it be interesting if we ended up, a few years from now, with neither CTC nor colonoscopy as the primary screening test, but rather an improved fecal test as our gold standard."

Harris is a national expert on cancer screening issues. He has served on the U.S. Preventive Services Task Force, a group that conducts scientific evidence reviews of a broad range of clinical preventive health care services and develops recommendations for primary care clinicians and health systems.


'/>"/>

Contact: Dianne Shaw
dgs@med.unc.edu
919-966-5905
University of North Carolina School of Medicine
Source:Eurekalert  

Related medicine news :

1. Disparities remain a challenge in health care says American College of Physicians
2. Guided Care improves physician satisfaction with patient/family communications
3. Global HIV/AIDS survey by IAPAC reveals critical gap in patient-physician conversations
4. Ochsner Health System Connects Community Physicians to Electronic Medical Records; Orion Health HIE Solution Provides Access to Healthcare Providers Across the Gulf South
5. ENT and Allergy Associates Adds Two Offices in Brooklyn, NY -- Practice Grows to 110 Physicians
6. Renowned Psychiatrist, Lyubov Y Gorelik, M.D., is selected to represent New York in The Leading Physicians of the World
7. Damon Runyon and Doris Duke Foundations announce partnership to support physician-scientists
8. Doctors and Medical Groups Increasingly Embrace Physician Marketing to Counter Changes in Health Care
9. The International Association of Anesthesiologists Places its Top Doctors in the Renowned Medical Publication, The Leading Physicians of the World.
10. Atlanta School of Sleep Medicine Offers Physician Board Review Course in October 2010
11. Are Advanced Practitioners Stepping on the Practice Turf of Physicians?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UNC physician authors editorial on cost-effectiveness study for colon cancer screening
(Date:12/6/2016)... Albuquerque, NM (PRWEB) , ... December 06, 2016 ... ... awarded JumpStart Autism Center with an Award of Distinction, recognizing the organization as ... needs providers that excel in the areas of clinical quality, staff satisfaction and ...
(Date:12/6/2016)... ... December 06, 2016 , ... Gateway Analytical, ... offering HIAC particle counting and sizing services for USP 788 and 789 particulate ... new service as a response to the needs of pharmaceutical and medical device ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... November 25th, when SevenPoint2 released the much-anticipated HydroFX for Water®. This first-of-its-kind ... design. Featuring one of the world’s most powerful antioxidants, molecular hydrogen, HydroFX ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... of the newly updated International Audit Protocol Consortium (IAPC) EHS audit protocol for ... protocols to understand the scope of their EHS regulatory obligations and rapidly collect, ...
(Date:12/6/2016)... Georgia (PRWEB) , ... December 06, 2016 , ... ... consecutive year to "Training" magazine’s 2017 Training Top 125 for their industry leading ... This prestigious, annual award recognizes USA as among the global elite in employer-sponsored ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... , Dec. 6, 2016 /PRNewswire/ - InMed Pharmaceuticals, ... today on its R&D program in the use ... pulmonary disease (COPD). In June, 2015 InMed initiated ... to identify the targets and potential active compounds ... COPD. Subsequently, with in vitro assays using human ...
(Date:12/5/2016)... WARSAW, Ind. , Dec. 5, 2016  Zimmer ... "Company") today announced that, pursuant to its previously-announced ... securities identified in the table below (collectively, the ... Notes were validly tendered and not validly withdrawn ... York City time, today, December 5, ...
(Date:12/5/2016)... 5, 2016 Sangamo BioSciences, Inc. (Nasdaq: ... presentation of preclinical and manufacturing data that support SB-525, its ... Annual Meeting of the American Society of Hematology (ASH) ... from December 3-6, 2016. "We have developed an ... we believe is highly competitive, and we remain on track ...
Breaking Medicine Technology: